IL1B and diabetic kidney disease: In the progression of DKD, GSDMD-NT forms pores in the glomerular endothelial cells and gradually triggers cell death, which releases amounts of pro-inflammatory cytokines, such as IL-1β, and activates strong inflammation [35].